BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3129357)

  • 1. [Efficacy of ofloxacin against Neisseria gonorrhoeae].
    Korting HC; Lukacs A
    Immun Infekt; 1988 Feb; 16(1):3-5. PubMed ID: 3129357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The in vitro activity of norfloxacin, ofloxacin and ciprofloxacin and other antibiotics in current use against Neisseria gonorrhoeae.
    Melby K; Faegri A
    APMIS; 1989 Apr; 97(4):347-50. PubMed ID: 2497756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activities of seven quinolone derivatives against Neisseria gonorrhoeae.
    van der Willigen AH; Degener JE; Vogel M; Stolz E; Wagenvoort JH
    Arzneimittelforschung; 1990 Jun; 40(6):684-5. PubMed ID: 2118763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial susceptibility of Neisseria gonorrheae strains in three regions of Armenia.
    Hovhannisyan G; von Schoen-Angerer T; Babayan K; Fenichiu O; Gaboulaud V
    Sex Transm Dis; 2007 Sep; 34(9):686-8. PubMed ID: 17621247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the in vitro activity of six antimicrobial agents against Neisseria gonorrhoeae.
    Belda Junior W; Velho PE; Fagundes LJ; Arnone M
    Rev Inst Med Trop Sao Paulo; 2007; 49(1):55-8. PubMed ID: 17384821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between in vitro quinolone susceptibility of Neisseria gonorrhoeae and outcome of treatment of gonococcal urethritis with single-dose ofloxacin.
    Kam KM; Lo KK; Chong LY; Au WF; Wong PY; Cheung MM
    Clin Infect Dis; 1999 May; 28(5):1165-6. PubMed ID: 10452657
    [No Abstract]   [Full Text] [Related]  

  • 7. Alterations of the pilQ gene in Neisseria gonorrhoeae are unlikely contributors to decreased susceptibility to ceftriaxone and cefixime in clinical gonococcal strains.
    Whiley DM; Jacobsson S; Tapsall JW; Nissen MD; Sloots TP; Unemo M
    J Antimicrob Chemother; 2010 Dec; 65(12):2543-7. PubMed ID: 20940180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence of ciprofloxacin resistant Neisseria gonorrhoeae in north India.
    Sethi S; Sharma D; Mehta SD; Singh B; Smriti M; Kumar B; Sharma M
    Indian J Med Res; 2006 May; 123(5):707-10. PubMed ID: 16873916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific Region, 2004.
    WHO Western Pacific Gonococcal Antimicrobial Surveillance Programme
    Commun Dis Intell Q Rep; 2006; 30(1):129-32. PubMed ID: 16637241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cephalosporin MIC creep among gonococci: time for a pharmacodynamic rethink?
    Chisholm SA; Mouton JW; Lewis DA; Nichols T; Ison CA; Livermore DM
    J Antimicrob Chemother; 2010 Oct; 65(10):2141-8. PubMed ID: 20693173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic susceptibility testing of Neisseria gonorrhoeae by disk-agar diffusion.
    Riou JY; Guibourdenche M; Courvalin P
    Ann Microbiol (Paris); 1981; 132B(1):23-39. PubMed ID: 6795982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoroquinolone resistance in Neisseria gonorrhoeae.
    Knapp JS; Fox KK; Trees DL; Whittington WL
    Emerg Infect Dis; 1997; 3(1):33-9. PubMed ID: 9126442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of molecular biology in the epidemiological characterization of Neisseria gonorrhoeae].
    Náder-García E; Mondragón-Jaimes VA; Conde-González CJ
    Salud Publica Mex; 1992; 34(3):292-300. PubMed ID: 1615347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Surveillance of Neisseria gonorrhoeae strains isolated in Toulouse. In vitro antibiotic sensitivity and plasmid content].
    Lefevre JC; Gaubert E; Tempesta MC; Lareng MB
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):635-8. PubMed ID: 3141883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emergence of quinolone-resistant Neisseria gonorrhoeae in Pakistan.
    Jabeen K; Khan E; Hasan R
    Int J STD AIDS; 2006 Jan; 17(1):30-3. PubMed ID: 16409676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vitro activity of ofloxacin against isolates of Neisseria gonorrhoeae.
    McEwen A; Roberts G
    J Antimicrob Chemother; 1988 Sep; 22 Suppl C():21-5. PubMed ID: 3141351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cluster of multidrug-resistant Neisseria gonorrhoeae with reduced susceptibility to the newer cephalosporins in Northern Greece.
    Tzelepi E; Daniilidou M; Miriagou V; Siatravani E; Pavlidou E; Flemetakis A
    J Antimicrob Chemother; 2008 Sep; 62(3):637-9. PubMed ID: 18556708
    [No Abstract]   [Full Text] [Related]  

  • 18. Cephalosporin susceptibility among Neisseria gonorrhoeae isolates--United States, 2000-2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Jul; 60(26):873-7. PubMed ID: 21734634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro susceptibility of Spanish isolates of Neisseria gonorrhoeae to cefditoren and five other antimicrobial agents.
    Vázquez JA; Martín E; Galarza P; Giménez MJ; Aguilar L; Coronel P
    Int J Antimicrob Agents; 2007 Apr; 29(4):473-4. PubMed ID: 17276040
    [No Abstract]   [Full Text] [Related]  

  • 20. [Resistance of Neisseria gonorrhoeae to 4 antibiotics: an analysis of the situation in Guangzhou in 2002].
    Fei S; Luo Q; Cao WL; Zhang XB
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Oct; 23(10):1099-100. PubMed ID: 14559707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.